Atrial fibrillation in hospitalized patients with end‐stage liver disease: temporal trends in prevalence and outcomes

2019 ◽  
Vol 40 (3) ◽  
pp. 674-684
Author(s):  
Hedong Han ◽  
Yingyi Qin ◽  
Yamei Yu ◽  
Xin Wei ◽  
Honglei Guo ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Liver Disease ◽  
Temporal Trends ◽  
Hospitalized Patients ◽  
End Stage Liver Disease ◽  
End Stage

scholarly journals Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end-stage liver disease (NACSELD) experience

Hepatology ◽  
2012 ◽  
Vol 56 (6) ◽  
pp. 2328-2335 ◽  
Author(s):  
Jasmohan S. Bajaj ◽  
Jacqueline G. O'Leary ◽  
K. Rajender Reddy ◽  
Florence Wong ◽  
Jody C. Olson ◽  
...  
Keyword(s):  
Liver Disease ◽  
North American ◽  
Hospitalized Patients ◽  
End Stage Liver Disease ◽  
The North ◽  
End Stage

553 DEMOGRAPHIC PREDICTORS OF SUCCESSFUL CARDIO-PULMONARY RESUSCITATION IN NATIONAL COHORT OF END-STAGE LIVER DISEASE HOSPITALIZED PATIENTS

2020 ◽  
Vol 158 (6) ◽  
pp. S-1280
Author(s):  
Savan Kabaria ◽  
Lauren Pioppo ◽  
Debashis Reja ◽  
Augustine Tawadros ◽  
Peter Dellatore ◽  
...  
Keyword(s):  
Liver Disease ◽  
Hospitalized Patients ◽  
End Stage Liver Disease ◽  
Demographic Predictors ◽  
Cardio Pulmonary Resuscitation ◽  
National Cohort ◽  
End Stage

Mo1028 Serum Ammonia Predicts Mortality in Hospitalized Patients With End-Stage Liver Disease

2014 ◽  
Vol 146 (5) ◽  
pp. S-989-S-990
Author(s):  
Vilas R. Patwardhan ◽  
Z. Gordon Jiang ◽  
Gail Piatkowski ◽  
Nezam H. Afdhal ◽  
Kenneth Mukamal ◽  
...  
Keyword(s):  
Liver Disease ◽  
Hospitalized Patients ◽  
End Stage Liver Disease ◽  
End Stage ◽  
Serum Ammonia

Palliative care access for hospitalized patients with end‐stage liver disease across the United States

Hepatology ◽  
2017 ◽  
Vol 66 (5) ◽  
pp. 1585-1591 ◽  
Author(s):  
Barret Rush ◽  
Keith R. Walley ◽  
Leo A. Celi ◽  
Neil Rajoriya ◽  
Mayur Brahmania
Keyword(s):  
United States ◽  
Palliative Care ◽  
Liver Disease ◽  
The United States ◽  
Hospitalized Patients ◽  
End Stage Liver Disease ◽  
Care Access ◽  
End Stage

Position Paper on Treatment of Hepatitis C in Romania, 2017. Part One

2017 ◽  
Vol 26 (2) ◽  
pp. 171-181 ◽  
Author(s):  
Liana Gheorghe ◽  
Ioan Sporea ◽  
Speranţa Iacob ◽  
Roxana Şirli ◽  
Anca Trifan ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Liver Disease ◽  
Hepatitis C ◽  
Limit Of Detection ◽  
Position Paper ◽  
Hcv Infection ◽  
Fixed Dose ◽  
Diagnostic Tools ◽  
End Stage Liver Disease ◽  
End Stage

Background & Aims: Hepatitis C Virus (HCV) infection is a common condition with endemic prevalence in some areas of the world. In Romania, the mean prevalence is about 3%. New treatments became available on the market in recent years and new drugs are in the pipeline. A re-evaluation of HCV therapy was considered mandatory. The Romanian Society of Gastroenterology and Hepatology undertook this task for the practitioners of this country.Methodology: A group of recognized experts was created who screened the available literature and the major available guidelines. A list of items requiring attention has been created. These items were discussed and rated. Decisions were taken by consensus.Recommendations: We present here the first of the two parts of our Society’s recommendations for chronic HCV infection treatment. An agreement was reached regarding the diagnostic tools, the assessment of severity and the up-dated therapy schedules.Conclusions: This Position Paper represents a guide for the assessment and the therapy of HCV infection. The recommendations are in concordance with other guidelines but are applied to the real-life conditions in this country.Abbreviations: DAAs: Direct-acting antivirals; DDIs: Drug-drug interactions; ESLD: End-stage liver disease; ESRD: End-stage renal disease; eGFR: Estimated glomerular filtration rate; EASL: European Association for the Study of the Liver; EMA: European Medicines Agency; FDA: US Food and Drug Administration; FDC: Fixed-dose combination; GT: Genotype; GRADE: Grading of Recommendations Assessment, Development and Evaluation; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; LT: Liver transplantation; LLD: Lower limit of detection; MELD score: Mayo-Clinic End-Stage Liver Disease score; ANMDM: National Agency of Medicines and Medical Devices; PPIs: Proton pump inhibitors; PWID: People who inject drugs; RCT: Randomized controlled trial; RDT: Rapid diagnostic test; RAS: Resistance-associated substitution; SRGH: Romanian Society of Gastroenterology and Hepatology; SAE: serious adverse events; SPC: Summary of Product Characteristics; SVR: Sustained virologic response.

Sign in / Sign up

Export Citation Format

Share Document